ASSESSMENT, INTERVENTION AND MEASUREMENT (AIM) The Assessment, Intervention and Measurement (AIM) facility is the only shared resource at MD Anderson that provides expertise in the science of collecting and managing patient-reported outcome data, assessing energy balance, and developing and implementing technology applications for behavioral assessment and intervention.
AIM i s a merger of the former CCSG core, Patient-Reported Outcomes, Survey and Population Research (PROSPR), and the CCSG Developing core, e-Health Technology (EHT). Consolidation of these two resources provided a more cost-efficient and integrated population research core facility.
AIM i s led by Dr. Susan Peterson (director), a professor in the Department of Behavioral Science, and Dr. Karen Basen-Engquist (co-director), a professor in the Department of Behavioral Science and the director of the Center for Energy Balance Research in Cancer Prevention and Survivorship. In the past 6 years, services have been provided to 105 center members in all 16 CCSG programs. Utilization of services provided by the AIM facility has increased 60% since grant Yr37 with 20% of the increase from the former PROSPR facility. Usage has diversified over the past 6 years with an increased number of users from clinical and translational CCSG programs. Peer review-funded usage accounted for 96% of AIM's total usage in Yr42; non-peer review funding accounted for 4% of its usage. In the past year, services have been provided to 36 center members in 12 of 16 CCSG programs with a similar fraction of peer- reviewed usage over the 6-year period. Population science programs accounted for 39% of AIM's usage, and clinical-translational CCSG programs' combined usage accounted for 50% of AIM's total usage. Current CCSG support accounts for 24% ($236,054) of the operating budget, chargebacks account for 45% ($441,576), and institutional support accounts for 31% ($306,914). In Yr44, AIM is requesting $278,346 (32%) in CCSG funding.
AIM has provided support for 75 publications since the previous grant period; 14 (19%) were in journals with IF >5.
The Specific Aims are:
Aim 1. To provide expertise in the science of collecting and managing patient- reported outcome data, including that collected with surveys, web applications, and mobile applications.
Aim 2. To provide expertise in energy balance research, including the assessment of diet, physical activity, and physical functioning, and in the delivery of physical activity interventions.
Aim 3. To provide expertise in the development and implementation of mobile, web, and sensor applications for behavioral assessment and intervention.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016672-43
Application #
9794664
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
43
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Wang, Jian; Shete, Sanjay (2018) Estimation of indirect effect when the mediator is a censored variable. Stat Methods Med Res 27:3010-3025
Chambers, Mark S; Rugo, Hope S; Litton, Jennifer K et al. (2018) Stomatitis associated with mammalian target of rapamycin inhibition: A review of pathogenesis, prevention, treatment, and clinical implications for oral practice in metastatic breast cancer. J Am Dent Assoc 149:291-298
Echeverria, Gloria V; Powell, Emily; Seth, Sahil et al. (2018) High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancer. Nat Commun 9:5079
Smith, Brian; Hsu, Yi-Hsin; Flores, Rene et al. (2018) Single oral dose acute and subacute toxicity of a c-MET tyrosine kinase inhibitor and CDK 4/6 inhibitor combination drug therapy. Am J Cancer Res 8:183-191
Kuerer, Henry M; Rauch, Gaiane M; Krishnamurthy, Savitri et al. (2018) A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy. Ann Surg 267:946-951
Tamari, Roni; Oran, Betul; Hilden, Patrick et al. (2018) Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34+ Selected and Unmodified Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 24:1079-1087
Khalaf, Ahmed M; Fuentes, David; Morshid, Ali I et al. (2018) Role of Wnt/?-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance. J Hepatocell Carcinoma 5:61-73
Horvath, Thomas D; Dagan, Shai; Lorenzi, Philip L et al. (2018) Positional stable isotope tracer analysis reveals carbon routes during ammonia metabolism of Aedes aegypti mosquitoes. FASEB J 32:466-477
Yang, Wei T; Parikh, Jay R; Stavros, A Thomas et al. (2018) Exploring the Negative Likelihood Ratio and How It Can Be Used to Minimize False-Positives in Breast Imaging. AJR Am J Roentgenol 210:301-306
Tetzlaff, M T; Messina, J L; Stein, J E et al. (2018) Pathological assessment of resection specimens after neoadjuvant therapy for metastatic melanoma. Ann Oncol 29:1861-1868

Showing the most recent 10 out of 12418 publications